A new treatment with for COVID-19 where the blood plasma of those who have survived from the virus is reported to have improved the condition of 10 patients, with Greek researchers conducting further trials.
The method itself involves the collection of plasma of recovered patients and given to those who have a severe form for the disease. Three doses, comprising 200-239 millilitres of fluid are then given over the span of two days, with a single donor able to help multiple patients.
(Sorry but I could not find photos of the famous haematology professors Marianna Politou and Vassiliki Papa, however hard I tried.)
University professors of the Medical School of Athens, Evangelos Terpos, Marianna Politou and Vassiliki Papa explained how the plasma of 261 volunteers was checked for antibodies.
The volunteers were either asymptomatic, had developed mild symptoms and recovered at home or had been hospitalised. A Polymerase Chain Reaction (PRC) test was conducted in which 82 healthy donors were eligible to donate plasma bases on techniques used at Greece's Pasteur Institute. The study is supposed to last for 20 months in order to determine the success of the new treatment, based on the survival rate of 100 COVID-19 patients after three weeks.
Changes in levels of antibodies are also being examined in recovered donors over a period of three, six and twelve months in order to determine how long they remain present after infection.
On April 28th, 2020, the polycentric phase and trials in which recovered or asymptomatic COVID-19 patients were given plasma after suffering from several forms of the disease. Another 22 researchers from six hospitals in Greece are also now involved in this effort.
The trials which have been approved by Greece's National Public Health Organisation is a step forward in developing a solid treatment for the horrible disease and helping patients to recover.
 |
| Laboratory Trials |
 |
| A Survivor Donor |
The method itself involves the collection of plasma of recovered patients and given to those who have a severe form for the disease. Three doses, comprising 200-239 millilitres of fluid are then given over the span of two days, with a single donor able to help multiple patients.
 |
| Professor Evangelos Terpos |
(Sorry but I could not find photos of the famous haematology professors Marianna Politou and Vassiliki Papa, however hard I tried.)
University professors of the Medical School of Athens, Evangelos Terpos, Marianna Politou and Vassiliki Papa explained how the plasma of 261 volunteers was checked for antibodies.
The volunteers were either asymptomatic, had developed mild symptoms and recovered at home or had been hospitalised. A Polymerase Chain Reaction (PRC) test was conducted in which 82 healthy donors were eligible to donate plasma bases on techniques used at Greece's Pasteur Institute. The study is supposed to last for 20 months in order to determine the success of the new treatment, based on the survival rate of 100 COVID-19 patients after three weeks.
Changes in levels of antibodies are also being examined in recovered donors over a period of three, six and twelve months in order to determine how long they remain present after infection.
On April 28th, 2020, the polycentric phase and trials in which recovered or asymptomatic COVID-19 patients were given plasma after suffering from several forms of the disease. Another 22 researchers from six hospitals in Greece are also now involved in this effort.
The trials which have been approved by Greece's National Public Health Organisation is a step forward in developing a solid treatment for the horrible disease and helping patients to recover.
No comments:
Post a Comment